Clinical Trial Update: A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA) [Phase 2]

View source ↗

Summary

Phase II study of DITPA, a thyroid hormone analog, for congestive heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• DITPA (3,5-diiodothyroacetic acid)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Congestive Heart Failure | Phase 2 | Status: TERMINATED